Dammann, I., Rohleder, C., & Leweke, F. M. (2024). Cannabidiol and its potential evidence-based psychiatric benefits: A critical review. Pharmacopsychiatry, 57(3), . https://doi.org/10.1055/a-2228-6118
Chicago Style (17th ed.) CitationDammann, Inga, Cathrin Rohleder, and F. Markus Leweke. "Cannabidiol and Its Potential Evidence-based Psychiatric Benefits: A Critical Review." Pharmacopsychiatry 57, no. 3 (2024). https://doi.org/10.1055/a-2228-6118.
MLA (9th ed.) CitationDammann, Inga, et al. "Cannabidiol and Its Potential Evidence-based Psychiatric Benefits: A Critical Review." Pharmacopsychiatry, vol. 57, no. 3, 2024, https://doi.org/10.1055/a-2228-6118.
Warning: These citations may not always be 100% accurate.